Biomatrix (BXM) Looking Great Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Philip H. Lee who wrote (117)	10/11/1997 7:18:00 PM
From: Donald Gravenor	of 569

The trend (in my opinion) is that Taxol will be prescribed more and more, as it is clearly a better drug than etoposide in non-small cell lung cancer, it's main indication. It takes several years before most oncologists come on board. NB it is no longer under patent, and anyone can produce and market it though (&not just Bristl). Prices will come down. DG

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next